Search

Your search keyword '"Obara, Wataru"' showing total 762 results

Search Constraints

Start Over You searched for: Author "Obara, Wataru" Remove constraint Author: "Obara, Wataru"
762 results on '"Obara, Wataru"'

Search Results

51. Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases

54. Association between nocturnal polyuria and 24‐h blood pressure fluctuations in males with lower urinary tract symptoms: A multicenter prospective study.

55. Postoperative recurrence detection using individualized circulating tumor DNA in upper tract urothelial carcinoma.

58. Figure 1 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

59. Figure 3 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

60. Figure 6 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

61. Table S2 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

62. Data from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

63. Figure 4 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

64. Supplementary Methods 1 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

65. Figure 2 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

66. Figure 5 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

67. Genome-wide association study identifies risk loci within the major histocompatibility complex region for Hunner-type interstitial cystitis

68. Retroperitoneal Malignant Lymphoma: A Case Report

69. Nivolumab in patients with unresectable locally advanced or metastatic urothelial carcinoma: CheckMate 275 2-year global and Japanese patient population analyses

72. Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial

74. Proton beam therapy for muscle-invasive bladder cancer: A systematic review and analysis with Proton-Net, a multicenter prospective patient registry database

75. Abstract 1416: Genomic features of renal cell carcinoma developed during end-stage renal disease and dialysis

76. PD17-05 GENOMIC FEATURES OF RENAL CELL CARCINOMA DEVELOPED DURING END-STAGE RENAL DISEASE AND DIALYSIS

77. PD46-01 DETECTION OF INDIVIDUALIZED MUTATIONS AND MONITORING OF POSTOPERATIVE RECURRENCE USING CIRCULATING TUMOR DNA IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA

78. Serum glucose, cholesterol and blood pressure levels in Japanese type 1 and 2 diabetic patients: BioBank Japan

79. Cholesterol levels of Japanese dyslipidaemic patients with various comorbidities: BioBank Japan

80. Overview of BioBank Japan follow-up data in 32 diseases

81. Characteristics and prognosis of Japanese male and female lung cancer patients: The BioBank Japan Project

82. Characteristics and prognosis of Japanese colorectal cancer patients: The BioBank Japan Project

83. Cross-sectional analysis of BioBank Japan clinical data: A large cohort of 200,000 patients with 47 common diseases

84. Characteristics of patients with liver cancer in the BioBank Japan project

85. Survival of macrovascular disease, chronic kidney disease, chronic respiratory disease, cancer and smoking in patients with type 2 diabetes: BioBank Japan cohort

86. Characteristics and prognosis of Japanese female breast cancer patients: The BioBank Japan project

87. Statin use and all-cause and cancer mortality: BioBank Japan cohort

88. Demographic and lifestyle factors and survival among patients with esophageal and gastric cancer: The Biobank Japan Project

89. Risk prediction models for mortality in patients with cardiovascular disease: The BioBank Japan project

90. Overview of the BioBank Japan Project: Study design and profile

91. Clinical and histopathological characteristics of patients with prostate cancer in the BioBank Japan project

93. The efficacy of molecular targeted therapy and nivolumab therapy for metastatic non‐clear cell renal cell carcinoma: A retrospective analysis using the Michinoku Japan urological cancer study group database.

96. Genetic analysis of right heart structure and function in 40,000 people

97. Supplementary Figure 1 from Molecular Features of Hormone-Refractory Prostate Cancer Cells by Genome-Wide Gene Expression Profiles

98. Supplementary Table 1 from Molecular Features of Hormone-Refractory Prostate Cancer Cells by Genome-Wide Gene Expression Profiles

99. Supplementary Figure 1 Legend from Molecular Features of Hormone-Refractory Prostate Cancer Cells by Genome-Wide Gene Expression Profiles

100. Genome-wide association study identifies risk loci within the major histocompatibility complex region for Hunner-type interstitial cystitis

Catalog

Books, media, physical & digital resources